These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2151392)

  • 41. Left ventricular hypertrophy and QT dispersion in hypertension.
    Mayet J; Shahi M; McGrath K; Poulter NR; Sever PS; Foale RA; Thom SA
    Hypertension; 1996 Nov; 28(5):791-6. PubMed ID: 8901825
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Left ventricular filling pattern in hypertensive patients after reversal of myocardial hypertrophy.
    Agati L; Fedele F; Penco M; Sciomer S; Dagianti A
    Int J Cardiol; 1987 Nov; 17(2):177-85. PubMed ID: 2960623
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Regression of myocardial hypertrophy in hypertensives on chronic beta-receptor block].
    Franz IW; Wiewel D; Behr M; Ketelhut R
    Dtsch Med Wochenschr; 1986 Apr; 111(14):530-4. PubMed ID: 2869930
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Left ventricular systolic function in relation to withdrawal of different pharmacological treatments in hypertensives with left ventricular hypertrophy.
    Muiesan ML; Agabiti-Rosei E; Romanelli G; Alari G; Barbier P; Fiorentini C; Muiesan G
    J Hypertens Suppl; 1988 Dec; 6(4):S97-100. PubMed ID: 2977183
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reversal of left ventricular hypertrophy in hypertensive patients treated with methyldopa. Lack of association with blood pressure control.
    Fouad FM; Nakashima Y; Tarazi RC; Salcedo EE
    Am J Cardiol; 1982 Mar; 49(4):795-801. PubMed ID: 6461238
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanical and non-mechanical factors in hypertensive hypertrophy, their clinical roles.
    Sugishita Y; Iida K; Yukisada K
    Jpn Circ J; 1990 May; 54(5):568-74. PubMed ID: 2172581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of long-term treatment with sustained-release nicardipine on left ventricular hypertrophy and function in patients with essential hypertension.
    Sumimoto T; Hiwada K; Ochi T; Matsubara W; Joh T; Imamura Y
    J Clin Pharmacol; 1994 Mar; 34(3):266-9. PubMed ID: 8021336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of left ventricular mass regression on cardiac function in hypertensive elderly individuals.
    Gerstenblith G; Schulman SP
    Eur J Clin Pharmacol; 1990; 39 Suppl 1():S25-8. PubMed ID: 2148148
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hemodynamic effects of the vascular selective calcium antagonist felodipine in patients with impaired left ventricular function.
    Gradman AH
    Am Heart J; 1992 Jan; 123(1):273-8. PubMed ID: 1729848
    [No Abstract]   [Full Text] [Related]  

  • 50. Left ventricular hypertrophy regression and function changes with ketanserin in elderly hypertensives.
    Vyssoulis GP; Karpanou EA; Pitsavos CE; Paleologos AA; Kourtis TK; Toutouzas PK
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():81-4. PubMed ID: 2149517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regression of left ventricular hypertrophy by felodipine or a combination of felodipine and metoprolol.
    Wetzchewald D; Klaus D; Garanin G; Hoffmann J; Lohr E
    J Cardiovasc Pharmacol; 1990; 15 Suppl 4():S48. PubMed ID: 1693727
    [No Abstract]   [Full Text] [Related]  

  • 52. [Cardiac performance in elderly hypertensives with left ventricular hypertrophy].
    Suzuki Y
    Nihon Ronen Igakkai Zasshi; 1992 Feb; 29(2):105-12. PubMed ID: 1533885
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Left ventricular hypertrophy and its reversal].
    Saragoça MA
    Arq Bras Cardiol; 1992 May; 58(5):345-51. PubMed ID: 1340706
    [No Abstract]   [Full Text] [Related]  

  • 54. [Results of a 2-year examination of patients with essential hypertension and left ventricular hypertrophy].
    Cifková R; Niederle P; Fridl P; Skalická G; Skibová E
    Kardiologiia; 1988 Jan; 28(1):27-30. PubMed ID: 2965771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reversal of left ventricular hypertrophy by drug treatment of hypertension.
    Schlant RC
    Chest; 1985 Sep; 88(3 Suppl):194S-196S, 198S. PubMed ID: 3161707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radiological heart enlargement in treated hypertensive men: a comparative study of chest X-ray examination and M-mode echocardiography.
    Samuelsson O; Hartford M; Wilhelmsen L; Berglund G; Wikstrand J
    J Intern Med; 1989 Feb; 225(2):77-83. PubMed ID: 2564044
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reversal of cardiac hypertrophy in humans.
    Tarazi RC; Fouad FM
    Hypertension; 1984; 6(6 Pt 2):III140-6. PubMed ID: 6240447
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reversal of cardiac and vascular hypertrophy by antihypertensive therapy.
    Hansson L
    Am Heart J; 1991 Mar; 121(3 Pt 2):995-8. PubMed ID: 1825445
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of hypertension with felodipine in patients with concomitant diseases.
    Gradman AH
    Clin Cardiol; 1993 Apr; 16(4):294-301. PubMed ID: 8458109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elevated circulating levels of insulin-like growth factor I in essential hypertensive patients with left ventricular hypertrophy.
    Laviades C; Mayor G; Diez J
    Arch Mal Coeur Vaiss; 1991 Aug; 84(8):1039-41. PubMed ID: 1835352
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.